Infection risk associated with anti-TNF-α agents: a review

Anti-TNF-α Inhibitors: A New Therapeutic Approach for Inflammatory Immune-Mediated Diseases: An Update upon Efficacy and Adverse Events

(2017) G. Murdaca et al.   INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY

Use of Anti-Tumor Necrosis Factor Alpha Therapy in Patients with Concurrent Rheumatoid Arthritis and Hepatitis B or Hepatitis C: A Retrospective Analysis of 32 Patients

(2014) Eleonora Ballanti et al.   DRUG DEVELOPMENT RESEARCH

Pharmacogenetics and Future Therapeutic Scenarios: What Affects the Prediction of Response to Treatment with Etanercept?

(2014) Giuseppe Murdaca et al.   DRUG DEVELOPMENT RESEARCH

Effects of TNF-Alpha Inhibitors on Circulating Th17 Cells in Patients Affected by Severe Psoriasis

(2014) Stefano Piaserico et al.   DRUG DEVELOPMENT RESEARCH

Pharmacogenetics of etanercept: role of TNF-α gene polymorphisms in improving its efficacy

(2014) Giuseppe Murdaca et al.   Expert Opinion on Drug Metabolism & Toxicology

Efficacy and safety of etanercept in chronic immune-mediated disease

(2014) Giuseppe Murdaca et al.   Expert Opinion On Drug Safety

Current therapies for the treatment of systemic sclerosis-related pulmonary arterial hypertension: efficacy and safety

(2014) Giuseppe Murdaca et al.   Expert Opinion On Drug Safety

Potential use of TNF-α inhibitors in systemic sclerosis

(2014) Giuseppe Murdaca et al.   Immunotherapy

Recurrence of active tuberculosis following resumption of anti-TNF-α therapy in a patient with Crohn's disease [Correspondence]

(2014) Mar Masiá et al.   INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE

TNF-  Antagonism Generates a Population of Antigen-Specific CD4+CD25+ T Cells That Inhibit Protective Immunity in Murine Histoplasmosis

(2014) G. S. Deepe et al.   JOURNAL OF IMMUNOLOGY

TNF-α Gene Polymorphisms: Association with Disease Susceptibility and Response to Anti-TNF-α Treatment in Psoriatic Arthritis

(2014) Giuseppe Murdaca et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Safety of Etanercept and Methotrexate in Patients with Rheumatoid Arthritis and Hepatitis C Virus Infection: A Multicenter Randomized Clinical Trial

(2014) F. Iannone et al.   JOURNAL OF RHEUMATOLOGY

Past hepatitis B virus infection in rheumatoid arthritis patients receiving biological and/or nonbiological disease-modifying antirheumatic drugs

(2014) Shunsuke Mori   Modern Rheumatology

Histoplasma capsulatum infection in Refractory Crohn's Disease of the Pouch on Anti-TNF Biological Therapy

(2013) Nan Lan et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Long-term safety of anti-TNF-α in PsA patients with concomitant HCV infection: a retrospective observational multicenter study on 15 patients

(2013) Luisa Costa et al.   CLINICAL RHEUMATOLOGY

Listeriosis in patients receiving biologic therapies

(2013) M. Bodro et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Use of leflunomide plus TNF-α inhibitors in rheumatoid arthritis

(2013) Giuseppe Murdaca et al.   Expert Opinion On Drug Safety

Effects of TNF-α inhibitors upon the mechanisms of action of VEGF

(2013) Giuseppe Murdaca et al.   Immunotherapy

Hepatitis B virus reactivation in HBsAg-positive patients with rheumatic diseases undergoing anti-tumor necrosis factor therapy or DMARDs

(2013) Young Ho Lee et al.   International Journal of Rheumatic Diseases

Risk of herpes/herpes zoster during anti-tumor necrosis factor therapy in patients with rheumatoid arthritis. Systematic review and meta-analysis

(2013) Helene Che et al.   JOINT BONE SPINE

A proposal for management of rheumatic disease patients with hepatitis B virus infection receiving immunosuppressive therapy

(2013) Masayoshi Harigai et al.   Modern Rheumatology

Free radicals and endothelial dysfunction: Potential positive effects of TNF-α inhibitors

(2013) Giuseppe Murdaca et al.   REDOX REPORT

Leishmaniasis during anti-tumor necrosis factor therapy: Report of 4 cases and review of the literature (additional 28 cases)

(2013) Luiz Sergio Guedes-Barbosa et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Tumor necrosis factor-α inhibitors and chronic hepatitis C: A comprehensive literature review

(2013) Maurizio Pompili   WORLD JOURNAL OF GASTROENTEROLOGY

Varicella zoster meningitis complicating combined anti-tumor necrosis factor and corticosteroid therapy in Crohn’s disease

(2013) Christopher Ma   WORLD JOURNAL OF GASTROENTEROLOGY

Influence of anti-TNF patient warning regarding avoidance of high risk foods on rates of listeria and salmonella infections in the UK

(2012) Rebecca Davies et al.   ANNALS OF THE RHEUMATIC DISEASES

Endothelial dysfunction in rheumatic autoimmune diseases

(2012) Giuseppe Murdaca et al.   ATHEROSCLEROSIS

Listeria infection in patients on anti-TNF treatment: Report of two cases and review of the literature

(2012) Cândida Abreu et al.   Journal of Crohns & Colitis

Determination of Lymphotoxin-Alpha Levels in Patients with Psoriatic Arthritis Undergoing Etanercept Treatment

(2012) Giuseppe Murdaca et al.   JOURNAL OF INTERFERON AND CYTOKINE RESEARCH

Fungal Infections Complicating Tumor Necrosis Factor α Blockade Therapy

(2012) Sotirios Tsiodras et al.   MAYO CLINIC PROCEEDINGS

Review article: prevention and management of hepatitis B and C infection in patients with inflammatory bowel disease

(2011) J. P. Gisbert et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Emerging biological drugs: A new therapeutic approach for Systemic Lupus Erythematosus. An update upon efficacy and adverse events

(2011) Giuseppe Murdaca et al.   AUTOIMMUNITY REVIEWS

Update upon efficacy and safety of TNF-α inhibitors

(2011) Giuseppe Murdaca et al.   Expert Opinion On Drug Safety

The role of Th17 lymphocytes in the autoimmune and chronic inflammatory diseases

(2011) Giuseppe Murdaca et al.   Internal and Emergency Medicine

Growing List of Infections Linked to TNF Blockers

(2011) B. M. Kuehn   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Pneumocystosis in a patient with Crohn's disease treated with combination therapy with adalimumab

(2011) Ana L. Desales et al.   Journal of Crohns & Colitis

Prospective study of reactivation of hepatitis B virus in patients with rheumatoid arthritis who received immunosuppressive therapy: evaluation of both HBsAg-positive and HBsAg-negative cohorts

(2011) Akihiro Tamori et al.   JOURNAL OF GASTROENTEROLOGY

Tuberculosis

(2011) Stephen D Lawn et al.   LANCET

Listeria monocytogenes infection in patients with inflammatory bowel diseases receiving anti-tumor necrosis factor therapy

(2011) J. M. Ramos et al.   REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS

Safety of anti-tumour necrosis factor agents in patients with chronic hepatitis C infection: a systematic review

(2011) A. M. G. Brunasso et al.   RHEUMATOLOGY

Reactivation of hepatitis B virus infection after cytotoxic chemotherapy or immunosuppressive therapy

(2011) María Luisa Manzano-Alonso   WORLD JOURNAL OF GASTROENTEROLOGY

Acute pulmonary histoplasmosis in a patient with uveitis after infliximab therapy

(2011) Lik Thai Lim et al.   INTERNATIONAL OPHTHALMOLOGY

Anti-Tumor Necrosis Factor-α Treatment with Infliximab for Disseminated Granuloma Annulare

(2010) Giuseppe Murdaca et al.   AMERICAN JOURNAL OF CLINICAL DERMATOLOGY

Risk of pneumocystosis after early discontinuation of prophylaxis among HIV-infected patients receiving highly active antiretroviral therapy

(2010) Chien-Yu Cheng et al.   BMC INFECTIOUS DISEASES

Advanced Age Is an Independent Risk Factor for Severe Infections and Mortality in Patients Given Anti–Tumor Necrosis Factor Therapy for Inflammatory Bowel Disease

(2010) Mario Cottone et al.   Clinical Gastroenterology and Hepatology

Use of tumor necrosis factor α inhibitors in hepatitis B surface antigen-positive patients: a literature review and potential mechanisms of action

(2010) Matthew B. Carroll et al.   CLINICAL RHEUMATOLOGY

The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement

(2010) I. Solovic et al.   EUROPEAN RESPIRATORY JOURNAL

Presentation and outcome of histoplasmosis in pediatric inflammatory bowel disease patients treated with antitumor necrosis factor alpha therapy: A case series

(2010) Jennifer L. Dotson et al.   INFLAMMATORY BOWEL DISEASES

Serious infections in patients with inflammatory bowel disease receiving anti-tumor-necrosis-factor-alpha therapy: An Australian and New Zealand experience

(2010) Ian C Lawrance et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Safety of tumor necrosis factor α blockers in hepatitis B virus occult carriers (hepatitis B surface antigen negative/anti-hepatitis B core antigen positive) with rheumatic diseases

(2010) R. Caporali et al.   ARTHRITIS CARE & RESEARCH

Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)

(2009) W. G. Dixon et al.   ANNALS OF THE RHEUMATIC DISEASES

Pneumocystis jirovecipneumonia in patients with rheumatoid arthritis treated with infliximab: A retrospective review and case-control study of 21 patients

(2009) Yukiko Komano et al.   ARTHRITIS AND RHEUMATISM

British Association of Dermatologists’ guidelines for biologic interventions for psoriasis 2009

(2009) C.H. Smith et al.   BRITISH JOURNAL OF DERMATOLOGY

Adalimumab safety in global clinical trials of patients with Crohnʼs disease

(2009) Jean-Frédéric Colombel et al.   INFLAMMATORY BOWEL DISEASES

European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease

(2009) J.F. Rahier et al.   Journal of Crohns & Colitis

Vascular effects of biologic agents in RA and spondyloarthropathies

(2009) Zoltán Szekanecz et al.   Nature Reviews Rheumatology

Safety of TNF-blocking agents in rheumatic patients with serology suggesting past hepatitis B state: results from a cohort of 21 patients

(2009) Caroline Charpin et al.   ARTHRITIS RESEARCH & THERAPY

Serum vascular endothelial growth factor and sublingual immunotherapy

(2008) G. Ciprandi et al.   ALLERGY

Traditional and non traditional risk factors in accelerated atherosclerosis in Systemic Lupus Erythematosus: Role of vascular endothelial growth factor (VEGATS Study)

(2008) Barbara Maria Colombo et al.   AUTOIMMUNITY REVIEWS

Delayed spinal infection after laminectomy in a patient with rheumatoid arthritis interruptedly exposed to anti-tumor necrosis factor α agents

(2008) Shunsuke Mori et al.   CLINICAL RHEUMATOLOGY

Serum vascular endothelial growth factor in allergic rhinitis and systemic lupus erythematosus

(2008) Giorgio Ciprandi et al.   HUMAN IMMUNOLOGY

Guidelines of care for the management of psoriasis and psoriatic arthritis

(2008) Alan Menter et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Severe Listeria meningoencephalitis in an infliximab-treated patient with Crohnʼs disease

(2007) Ferenc Izbéki et al.   INFLAMMATORY BOWEL DISEASES